A study of patients at a transplant center found a high burden of bloodstream infections (BSIs) caused by multidrug-resistant organisms (MDROs) following organ transplant, researchers reported yesterday in JAC-Antimicrobial Resistance.
To describe the epidemiology of BSIs in the year after solid organ transplant (SOT), researchers at Houston Methodist Hospital analyzed data on patients who received kidney, liver, heart, and multi-organ transplants from June 2016 to September 2021. They examined BSIs that occurred within a year of the transplant and classified MDRO phenotypes for Staphylococcus aureus, enterococci, Enterobacterales, Pseudomonas aeruginosa, and Candida spp. They also compared BSI characteristics between SOT types and determined risk factors for 90-day mortality.
Substantial proportion of isolates multidrug-resistant
Of the 2,293 patients (54.6% kidney, 28.9% liver, 9.6% heart, and 7.0% multi-organ transplant) included in the study, 8.5% developed BSIs, which were most common after multi-organ (23.1%) and liver (11.3%) transplants. Among 196 patients with BSI, there were 313 BSI episodes, yielding 323 unique isolates, 45.5% of which were MDROs.
Liver transplant recipients harbored the most MDROs (53.4%), followed by multi-organ transplant recipients (49.4%). The most frequent MDROs were vancomycin-resistant enterococci (VRE) (comprising 69.8% of enterococci) and extended-spectrum beta-lactamase–producing and carbapenem-resistant Enterobacterales (CRE) (29.2% and 27.2% of Enterobacterales, respectively). Overall mortality after BSI was 9.7%, but VRE was the only MDRO independently associated with an increase in mortality (adjusted odds ratio, 6.0; 95% confidence interval, 1.7 to 21.3).
The study authors say that while the BSI incidence was lower than found in a recent study conducted in Denmark, the substantial proportion of MDROs and the number of patients with more than one BSI episode are concerns.
"Although BSI incidence was lower than in previous studies, the emergence of MDR phenotypes, especially CRE and VRE infections after liver and multi-organ transplantation, is worrisome," they wrote. "Our results can guide future research on strategies to decrease burden and impact of MDROs after SOT."